Reuters logo
BRIEF-Edge Therapeutics enters commercial supply agreement for EG-1962 with Oakwood Laboratories
July 6, 2017 / 10:51 AM / 3 months ago

BRIEF-Edge Therapeutics enters commercial supply agreement for EG-1962 with Oakwood Laboratories

July 6 (Reuters) - Edge Therapeutics Inc

* Edge Therapeutics announces commercial supply agreement for EG-1962 with Oakwood Laboratories

* Edge Therapeutics Inc - also entered agreement for initial product launch of EG-1962

* Edge Therapeutics Inc - entered supply agreement, amended and restated development agreement with Oakwood Laboratories for manufacturing of EG-1962 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below